1300015I baylor college of medicine; vteu; to FY.2017.B8C12.0080--15 task area B-C phase II vaccine trial for influenza; H7N9 flu can 8030247; $3,900,915
Ended Awarded Last action
- Contract number
- HHSN27200015
- Awardee
-
Baylor College Of Medicine UEI FXKMA43NTV21
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,161,894
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (VTEU) Award Notice · Posted Mar 29, 2012
- Contract value 100% obligated
- $2,161,893.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Houston, TX 77030, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$5,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$1,734,021 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,900,915 |
About this award
This federal contract award is for a $3,900,915 delivery order issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Baylor College of Medicine, a private university and non-profit organization located in Houston, Texas. The contract is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical trials for influenza and other infectious disease vaccines and treatments.
The contract tasks Baylor College of Medicine with conducting a Phase II clinical trial to assess the safety and immunogenicity of an influenza A(H7N9) vaccine. Baylor has subcontracted with Kelsey Research, a non-profit organization, to assist with subject recruitment and enrollment. The University of Texas Medical Branch at Galveston, a state research institution, is also involved as a subcontractor to provide protocol development and implementation support. The contract has a completion date of December 31, 2023 and does not include any set-aside designations.
Quick answers
Who was awarded contract HHSN27200015?
HHSN27200015 was awarded to Baylor College Of Medicine by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 27, 2017.
How much is contract HHSN27200015 worth?
The government has obligated $2,161,894 on HHSN27200015.
Is contract HHSN27200015 an order under another contract?
Yes. HHSN27200015 is a delivery order under HHSN272201300015I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200015 competed?
The extent of competition for HHSN27200015 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award